Protrait

 

Stephen L. Rose, MD
Professor (CHS)
Director of Fellowship in Gynecologic Oncology, Division Director of Gynecologic Oncology


Gynecologic Oncology


Office Address
UW Hospital and Clinics, Room: H4-636
600 Highland Ave
Madison, WI, 53705


Administrative Assistant
Cortney Wood
cwood3@wisc.edu
(608) 263-1210


Education

B.S. Butler University, Indianapolis, IN

M.D. Indiana University School of Medicine , Indianapolis, IN

Residency St. Vincent Hospital and Health Services, Indianapolis, IN

Fellowship The University of Iowa Hospitals and Clinics, Iowa City, IA


Certifications

American Board of Obstetrics and Gynecology


Department Leadership Role

Director, Division of Gynecologic Oncology

Director, Fellowship in Gynecologic Oncology


Honors and Awards

America’s Top Doctors - Castle Connolly Medical Ltd.
 
“Top Doctors in Madison” - Madison Magazine
 
Invited Gyn Onc Oral Board Examiner - American Board of Obstetrics and Gynecology
 
Liz Tilberis Scholars Award from the Ovarian Cancer Research Foundation


Memberships

Society of Gynecologic Oncology Full Member

Fellow of the American College of Obstetrics and Gynecology

American Gynecological and Obstetrical Society Fellow

Gynecologic Oncology Group/NRG

Dr. Rose's Research

Research Focus: Quality of life issues for gynecologic cancer patients, gynecologic cancer survivorship, and basic and translational science research of gynecologic cancers.


Rose co-authors new reporting system for ovarian and uterine masses

UW Ob-Gyn Division of Gynecologic Oncology Director Stephen Rose, MD was part of an international committee that developed a new data and reporting system to bring consistency and accuracy to assessing ovarian masses and lumps within uterine tissue.

Rose helped create the Ovarian-Adnexal Reporting and Data System (O-RADS), which is based on vocabulary published in 2018 by the O-RADS ultrasound working group and guidelines established by the International Ovarian Tumor Analysis (IOTA) group. The tool recommends categories to help distinguish risk of malignancy.

Learn more about O-RADS here – amazing work, Dr. Rose!


Rose accepted as AGOS fellow

Congratulations to UW Ob-Gyn Division of Gynecologic Oncology Director Stephen Rose, MD, who was recently accepted as an active fellow of the American Gynecological and Obstetrical Society (AGOS)!

AGOS advances the health of women by providing dedicated leadership and promoting excellence in research, education and medical practice. In order to be considered as an AGOS fellow, candidates must be outstanding leaders in academic obstetrics and gynecology with good character, high ethical standing and recognized ability as a teacher, physician and scholar.

Amazing work, Dr. Rose!


Wang publishes in Case Reports in Obstetrics and Gynecology

Congratulations to UW Ob-Gyn resident Connor Wang, MD, PGY-1, who is lead author on a new article in Case Reports in Obstetrics and Gynecology!

Grade 4 Pneumonitis in a Patient Treated with a Combination of Gemcitabine and Docetaxel for Recurrent Leiomyosarcoma of the Uterus” describes a case of inflamed lung tissue, followed by other complications, in a patient being treated for uterine cancer using two particular chemotherapy drugs. The case study includes important suggestions for other providers using those drugs in their treatment plans:

Physicians should not only be aware of gemcitabine and docetaxel’s potential to cause life-threatening pulmonary injuries but also recognize the variability in clinical presentations and treatment responses, the radiographic findings of these lung toxicities, and the need for early corticosteroid therapy in these cases.

UW Ob-Gyn gynecologic oncologists Stephen Rose, MD and Ryan Spencer, MD co-authored the article with Wang. Read the whole case study here.

Amazing work, Dr. Wang!


Rose coauthors article in Journal of Clinical Oncology

UW Ob-Gyn Division of Gynecologic Oncology Director Stephen Rose, MD, co-authored an article published in the Journal of Clinical Oncology!

Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study” compares the oncologic outcomes between open and minimally invasive radical hysterectomies performed in academic medical institutions in the United States. The study’s secondary goal was to determine difference in outcomes based on tumor size by comparing preoperative and postoperative tumor size.

“In this large multi-institutional retrospective study from academic medical institutions in the United States, we found that the minimally invasive radical hysterectomy was associated with worse recurrence-free survival—but not OS—compared with open approach. In patients with tumor size ≤ 2 cm on final pathology, a higher recurrence rate was noted in the minimally invasive approach. In addition, our results highlight the limitations of clinical evaluation of tumor size in making operative decisions for cervical cancer.”

Read the whole study here. Congratulations, Dr. Rose!


UW Ob-Gyn gyn onc faculty to present at OncLive State of the Science Summit – May 12

Learn about the latest in ovarian cancer care and treatment from the UW Ob-Gyn Division of Gynecologic Oncology at the OncLive State of the Science Summit on May 12, 2020. It’s free to attend this event at the Sheraton Madison Hotel, 5-9pm!

Gynecologic Oncology Division Director Stephen Rose, MD is program chair for the event. Speakers include Ahmed Al-Niaimi, MD, Lisa Barroilhet, MD, Ellen Hartenbach, MD, Ryan Spencer, MD and Sumer Wallace, MDThey’ll cover topics like molecular testing, surgical options, PARP inhibitors, immunotherapy and more in the treatment and management of ovarian cancer.

More information available on this flyer (PDF). You can register to attend this free event here!


Rose discusses clinical trials in new video from UW Carbone Cancer Center

UW Ob-Gyn Division of Gynecologic Oncology Director Stephen Rose, MD helps explain the importance of clinical trials for cancer research in a new video from the UW Carbone Cancer Center.

In the video, Rose and others explain what clinical trials are, why they can be important patients, how the trials process works at Carbone, and why trials are a crucial part of ongoing cancer research.

Watch the whole video here!


First HAGO Conference was a great success!

On September 10-11, the UW Ob-Gyn Division of Gynecologic Oncology hosted the first-ever Heartland Association of Gynecologic Oncology (HAGO) meeting. More than 70 gynecologic oncology professionals tuned in for the virtual conference, which included two keynote presentations and 21 research abstract presentations.

HAGO was founded in 2020 by UW Ob-Gyn Division of Gyn Onc Director Stephen Rose, MD, and the program committee included Ryan Spencer, MD and UW Ob-Gyn Gyn Onc fellowship graduates Andrea O’Shea, MD and Shitanshu Uppal, MD.

Of the 21 abstracts selected for presentation, five were from our department (Matthew Wagar, MD with mentor Sumer Wallace, MDWagar with mentor Makeba Williams, MDShannon Rush, MD with mentor Steve Rose, MDRachel Mojdehbakhsh, MD with mentor Ryan Spencer, MD; and Connor Wang, MD with mentor Spencer).

UW Ob-Gyn Gyn Onc fellow Shannon Rush, MD earned the first Award for Clinical Research for her abstract “65 Revisited: A Revised Markov Model for Evaluating Oophorectomy at the Time of Hysterectomy for Benign Disease”!

Lisa Barroilhet, MD was also an invited distillation presenter and UW Ob-Gyn Department Chair Laurel Rice, MD gave a keynote address and received the inaugural HAGO Award for Service and Leadership.

Our congratulations to everyone involved in planning and preparing the HAGO Conference – incredible work!


Mojdehbakhsh published in Gynecologic Oncology Reports

A quality improvement study by lead author Rachel Mojdehbakhsh, MD, PGY-2, was published in Gynecologic Oncology Reports. Co-authors include Stephen Rose, MD, Megan Peterson, DNP, Laurel Rice, MD, and Ryan Spencer, MD, all of the UW Ob-Gyn Division of Gynecologic Oncology.

In light of the COVID-19 pandemic that began in early 2020, industry organizations like the National Comprehensive Cancer Network recommended transitioning some appointments to telemedicine. Mojdehbakhsh’s study, “A quality improvement pathway to rapidly increase telemedicine services in a Gynecologic Oncology clinic during the COVID-19 pandemic with patient satisfaction scores and environmental impact”, outlines efforts at the UW Carbone Cancer Center’s gynecologic oncology clinic to move appointments to telehealth platforms over a short period of time. The study also assessed patient satisfaction with telemedicine visits, and environmental impact of moving visits online.

With multidisciplinary team planning and standardized note templates, transitioning 50% of encounters to telemedicine and achieving high rates of consent documentation were accomplished in four weeks. This increase in telemedicine represented a measurable decrease in the amount of CO  2 emissions. Additionally, patients were overwhelmingly satisfied.”

Read the whole study here – incredible work, Dr. Mojdehbakhsh and Gyn Onc division team!